ESMO 2026 has ended. This guide stays up as the record of who was there. Next: ESMO 2027, Sep 17–21, 2027 in Barcelona
Hospital Clínic de Barcelona at ESMO 2026
Oct 23–27, 2026 Madrid, Spain ~37k attendees Website
Hospital Clínic de Barcelona takes part in 23 sessions at ESMO 2026 in Madrid. Its program covers treatment choices and cancer biology across lung, urinary, gastrointestinal and other cancers. Topics include detecting occupational lung cancer through structured assessment and predicting early pancreatic cancer recurrence with machine learning.
| Organization | ESMO 2026 Attendance |
|---|---|
Hospital Clínic de Barcelona Barcelona, Spain | |
Public university hospital in Barcelona, Spain, affiliated with the University of Barcelona, with a linked biomedical research institute. | Poster Fri Oct 23 13:00–15:00 Poster Fri Oct 23 13:00–15:00 Poster Fri Oct 23 13:00–15:00 NRF2 transcriptomic activity as a candidate marker of an immunoregulatory inflamed phenotype in T-cell inflamed metastatic melanoma Melanoma & skin cancersBiomarkers & precision oncology Poster Fri Oct 23 13:00–15:00 Oncologist-led sentinel network improves detection of occupational sinonasal cancer: Results from the prospective CENTINELA-01 study Sarcoma, CNS, head & neck and rare cancers Talk Fri Oct 23 14:00–14:15 Smart chemotherapy: ADCs and beyond Lung & thoracic cancers Poster Fri Oct 23 15:15–16:00 Satellite Fri Oct 23 18:15–18:20 Welcome and introductions Genitourinary cancers Satellite Fri Oct 23 18:20–19:00 Chair Sat Oct 24 10:15–11:45 Rapid oral 1: Genitourinary tumours, renal and urothelial Genitourinary cancers Abstract Sat Oct 24 10:30–10:45 Invited Discussant 4738O , 4739O and 4748RO Genitourinary cancers Talk Sat Oct 24 12:00–12:15 Targeted therapies Nursing & supportive care Chair Sat Oct 24 12:00–12:50 What oncologists should know about managing toxicities of novel therapies Nursing & supportive care Satellite Sat Oct 24 18:30–20:00 Pfizer - Breaking the Treatment Plateau in Advanced NSCLC: Antibody Therapy Redefined Lung & thoracic cancers Satellite Sat Oct 24 19:15–19:40 After Resistance: Emerging ADCs in 2L advanced NSCLC Lung & thoracic cancers Satellite Sat Oct 24 19:40–19:55 Looking Ahead: The Future Puzzle of aNSCLC Treatment Lung & thoracic cancers Talk Sun Oct 25 10:15–10:35 Presentation by Expert Biomarkers & precision oncology Poster Sun Oct 25 12:00–12:45 Poster Sun Oct 25 12:00–12:45 Poster Sun Oct 25 12:00–12:45 Chair Sun Oct 25 13:00–14:30 Talk Sun Oct 25 13:54–14:12 Satellite Sun Oct 25 14:00–14:15 The Evolving Algorithm: Sequencing Innovative Strategies Lung & thoracic cancers Satellite Sun Oct 25 14:15–14:30 Faculty Roundtable and Audience Q&A Lung & thoracic cancers Abstract Sun Oct 25 15:05–15:15 Abstract Sun Oct 25 16:40–16:45 Talk Mon Oct 26 10:55–11:15 Next-generation therapies: ADCs, small molecules, and rational combinations Gastrointestinal cancers Chair Mon Oct 26 13:00–14:30 Abstract Mon Oct 26 15:07–15:12 Satellite Mon Oct 26 18:30–18:35 Introduction Lung & thoracic cancersGastrointestinal cancers Satellite Mon Oct 26 18:30–20:00 Revolution Medicines - Advances in RAS-targeted therapies: emerging clinical data and future directions in NSCLC and PDAC Lung & thoracic cancersGastrointestinal cancers Satellite Mon Oct 26 19:00–19:30 Emerging RAS-targeted therapies and treatment strategies for PDAC Lung & thoracic cancersGastrointestinal cancers Satellite Mon Oct 26 19:45–20:00 Conclusions and Q&A Lung & thoracic cancersGastrointestinal cancers Chair Tue Oct 27 09:00–13:00 |
Find decision makers at Hospital Clínic de Barcelona
Tell us what you sell and we’ll find the people at Hospital Clínic de Barcelona most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction